Researchers at Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen have examined a man who has received more than 200 vaccinations against COVID-19. They learned of his case via newspaper ...
Mar 5, 2024
0
167
A research team from the University of Rovira i Virgili, University of Ohio and the University of Texas has developed an innovative method that allows fibromyalgia to be reliably diagnosed from a blood sample. Identifying ...
Mar 4, 2024
0
15
A new Danish study may be the first step towards a much faster and more accurate diagnosis of a wide range of conditions that require regulation of the body's stress hormone, cortisol.
Mar 1, 2024
0
43
A patient with gastrointestinal problems pays his doctor a visit. The doctor orders a stool test that will measure fecal bile acids, compounds made by the liver that can also be modified by the intestinal microbiome and are ...
Mar 1, 2024
0
0
A study of people with obstructive sleep apnea suggests that high CPAP pressures may explain why the machines do not lower a patient's risk of heart disease, which is about two to three times higher than average.
Feb 26, 2024
0
0
A new UCLA Health study found Kundalini yoga provided several benefits to cognition and memory for older women at risk of developing Alzheimer's disease, including restoring neural pathways, preventing brain matter decline, ...
Feb 26, 2024
0
8
A research project supported by the National Institutes of Health has developed a tool to rapidly and inexpensively diagnose sarcoidosis, a chronic inflammatory disease marked by the growth of tiny lumps called granulomas ...
Feb 22, 2024
0
0
The Wistar Institute's associate professor Mohamed Abdel-Mohsen, Ph.D., has demonstrated, with his lab and collaborators, a connection between viral damage to the gut and premature biological aging.
Feb 22, 2024
0
15
University of Waterloo researchers have developed a new blood testing method that can detect potent opioids much faster than traditional approaches and potentially save lives.
Feb 22, 2024
0
37
SARS-CoV-2 triggers the production of the antiviral protein IFN-γ, which is associated with fatigue, muscle ache and depression. New research shows that in long COVID patients, IFN-y production persists until symptoms improve, ...
Feb 21, 2024
0
115
